These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1601501)

  • 41. Occult HBV infection in multi transfused thalassemia patients.
    Sabat J; Dwibedi B; Dash L; Kar SK
    Indian J Pediatr; 2015 Mar; 82(3):240-4. PubMed ID: 24928107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of serum markers of infection and naturally acquired immunity to hepatitis B virus in transfused children treated at a children's hospital in Salvador, Bahia: A cross-sectional study.
    Martinez VO; D'Arede SO; de Almeida ES; Lima FWM
    Pediatr Hematol Oncol; 2018; 35(7-8):422-426. PubMed ID: 30588876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B antigen - post transfusion studies in Papua New Guinea.
    Woodfield DG
    Trop Geogr Med; 1977 Sep; 29(3):257-65. PubMed ID: 595131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions.
    Singh H; Pradhan M; Singh RL; Phadke S; Naik SR; Aggarwal R; Naik S
    Vox Sang; 2003 May; 84(4):292-9. PubMed ID: 12757503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.
    De Virgiliis S; Fiorelli G; Fargion S; Cornacchia G; Sanna G; Cossu P; Murgia V; Cao A
    J Clin Pathol; 1980 Oct; 33(10):949-53. PubMed ID: 7430360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Australia antigen (HBsAg) in thallassemia children receiving multiple transfusions.
    Mehta KP; Patil HL; Merchant SM; Babar ST; Baxi AJ; Bapat JP
    Indian Pediatr; 1977 Jun; 14(6):455-9. PubMed ID: 604273
    [No Abstract]   [Full Text] [Related]  

  • 47. Concomitant hepatitis B surface antigen and antibody in thirteen patients.
    Foutch PG; Carey WD; Tabor E; Cianflocco AJ; Nakamoto S; Smallwood LA; Gerety RJ
    Ann Intern Med; 1983 Oct; 99(4):460-3. PubMed ID: 6625377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serologic evidence of hepatitis A and B virus infections in thalassemia patients: a retrospective study.
    Stevens CE; Silbert JA; Miller DR; Dienstag JL; Purcell RH; Szmuness W
    Transfusion; 1978; 18(3):356-60. PubMed ID: 664004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis A and B infections in transfusion-dependent thalassaemia from endemic areas.
    Li AM; Chang WK
    J Paediatr Child Health; 1991 Aug; 27(4):228-31. PubMed ID: 1958422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Half life of transfused anti-HBs.
    Frösner GG; Sugg U; Schneider W
    Dev Biol Stand; 1975; 30():316-9. PubMed ID: 1204967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Horizontal transmission of hepatitis B virus infection in household contacts, Pune, India.
    Dhorje SP; Pavri KM; Prasad SR; Sehgal A; Phule DM
    J Med Virol; 1985 Jun; 16(2):183-9. PubMed ID: 3891915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis, type B in haemophiliacs. Relation to the source of clotting factor concentrates.
    Holsteen V; Skinhoj P; Cohn J
    Scand J Haematol; 1977 Mar; 18(3):214-8. PubMed ID: 847395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Significance of hepatitis B virus markers in children with acute and chronic hepatitis B in the familial spread of the infection].
    Miminoshvili MI; Ketiladze ES; Shakhgil'dian IV; Kozlova TP; Vorozhbieva TE
    Vopr Virusol; 1987; 32(1):63-7. PubMed ID: 3577109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disappearance after two years of HBsAg and HBsAb in multiply transfused thalassemic patients and in their relatives in Sardinia.
    Scalise G; Cuccuru G; Stangoni A; Mela G; Cutillo S; Dore A; Gioannini P
    Panminerva Med; 1979; 21(1):7-10. PubMed ID: 492747
    [No Abstract]   [Full Text] [Related]  

  • 55. Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.
    Papaevangelou G; Frösner G; Economidou J; Parcha S; Roumeliotou A
    Br Med J; 1978 Mar; 1(6114):689-91. PubMed ID: 630296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accidental transfusion of blood containing HBsAg or anti-HBs.
    Babes VT; Cajal N; Filipescu Z; Milcov V
    Virologie; 1977; 28(3):173-8. PubMed ID: 898652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
    Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
    Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunologic studies on HBs-antigen. I. HBs-antigenemia and anti-HBs after transfusion of HBs-antigen stored blood (proceedings)].
    Berthold H; Kleine N
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):295-7. PubMed ID: 983516
    [No Abstract]   [Full Text] [Related]  

  • 59. Seroepidemiology of hepatitis B in a population of children in central Tunisia.
    Said S; Larouze B; Biaud JM; Sabbagh K; Yang C; Gaumer B; Jemmali M; Gaudebout C
    Int J Epidemiol; 1985 Jun; 14(2):313-7. PubMed ID: 4018999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Viral infection markers in foci of chronic hepatitis B].
    Nechaev VV; Mikhaĭlov MI; Mukomolov SL; Shliakhtenko LI; Zubov SV
    Vopr Virusol; 1988; 33(5):554-8. PubMed ID: 2975430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.